Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma? (Q37537892)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19570696%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19570696%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19570696%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sobia Zafar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19570696%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2

Alan G T Payne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19570696%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19570696%20AND%20SRC:MED&resulttype=core&format=json

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19570696%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19570696%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19570696%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

e1-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19570696%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Are bisphosphonates the suitable anticancer drugs for the elderly?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Development of bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-containing metabolite.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Uncovering the cause of "phossy jaw" Circa 1858 to 1906: oral and maxillofacial surgery closed case files-case closed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Phosphorus necrosis of the jaw: 'phossy jaw'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Avascular necrosis of the jaws: risk factors in metastatic cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphanates and Oral Cavity Avascular Bone Necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Osteonecrosis of the jaws associated with cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonates and bone necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Osteonecrosis of the jaw: who gets it, and why?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Opportunistic osteomyelitis in the jaws of children on immunosuppressive chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Treatment with infliximab: Implications in oral surgery? A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonates and bisphosphonate induced osteonecrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Osteonecrosis and bisphosphonates in oral and maxillofacial surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonate-associated osteonecrosis of the auditory canal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Osteonecrosis of the jaw and bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Factors associated with osteonecrosis of the jaw among bisphosphonate users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

"Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Oral bisphosphonates and dental implants: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Treatment results of bisphosphonate-related osteonecrosis of the jaws

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027

Bisphosphonate osteonecrosis: a protocol for surgical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.04.027